Literature DB >> 20421921

Malignant precursor cells pre-exist in human breast DCIS and require autophagy for survival.

Virginia Espina1, Brian D Mariani, Rosa I Gallagher, Khoa Tran, Stacey Banks, Joy Wiedemann, Heather Huryk, Claudius Mueller, Luana Adamo, Jianghong Deng, Emanuel F Petricoin, Lucia Pastore, Syed Zaman, Geetha Menezes, James Mize, Jasbir Johal, Kirsten Edmiston, Lance A Liotta.   

Abstract

BACKGROUND: While it is accepted that a majority of invasive breast cancer progresses from a ductal carcinoma in situ (DCIS) precursor stage, very little is known about the factors that promote survival of DCIS neoplastic cells within the hypoxic, nutrient deprived intraductal microenvironment. METHODOLOGY AND PRINCIPAL
FINDINGS: We examined the hypothesis that fresh human DCIS lesions contain pre-existing carcinoma precursor cells. We characterized these cells by full genome molecular cytogenetics (Illumina HumanCytoSNP profile), and signal pathway profiling (Reverse Phase Protein Microarray, 59 endpoints), and demonstrated that autophagy is required for survival and anchorage independent growth of the cytogenetically abnormal tumorigenic DCIS cells. Ex vivo organoid culture of fresh human DCIS lesions, without enzymatic treatment or sorting, induced the emergence of neoplastic epithelial cells exhibiting the following characteristics: a) spontaneous generation of hundreds of spheroids and duct-like 3-D structures in culture within 2-4 weeks; b) tumorigenicity in NOD/SCID mice; c) cytogenetically abnormal (copy number loss or gain in chromosomes including 1, 5, 6, 8, 13, 17) compared to the normal karyotype of the non-neoplastic cells in the source patient's breast tissue; d) in vitro migration and invasion of autologous breast stroma; and e) up-regulation of signal pathways linked to, and components of, cellular autophagy. Multiple autophagy markers were present in the patient's original DCIS lesion and the mouse xenograft. We tested whether autophagy was necessary for survival of cytogenetically abnormal DCIS cells. The lysosomotropic inhibitor (chloroquine phosphate) of autophagy completely suppressed the generation of DCIS spheroids/3-D structures, suppressed ex vivo invasion of autologous stroma, induced apoptosis, suppressed autophagy associated proteins including Atg5, AKT/PI3 Kinase and mTOR, eliminated cytogenetically abnormal spheroid forming cells from the organ culture, and abrogated xenograft tumor formation.
CONCLUSIONS: Cytogenetically abnormal spheroid forming, tumorigenic, and invasive neoplastic epithelial cells pre-exist in human DCIS and require cellular autophagy for survival.

Entities:  

Mesh:

Year:  2010        PMID: 20421921      PMCID: PMC2857649          DOI: 10.1371/journal.pone.0010240

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  52 in total

1.  Gene expression profiles of human breast cancer progression.

Authors:  Xiao-Jun Ma; Ranelle Salunga; J Todd Tuggle; Justin Gaudet; Edward Enright; Philip McQuary; Terry Payette; Maria Pistone; Kimberly Stecker; Brian M Zhang; Yi-Xiong Zhou; Heike Varnholt; Barbara Smith; Michelle Gadd; Erica Chatfield; Jessica Kessler; Thomas M Baer; Mark G Erlander; Dennis C Sgroi
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-24       Impact factor: 11.205

2.  Outcome of patients with ductal carcinoma in situ untreated after diagnostic biopsy: results from the Nurses' Health Study.

Authors:  Laura C Collins; Rulla M Tamimi; Heather J Baer; James L Connolly; Graham A Colditz; Stuart J Schnitt
Journal:  Cancer       Date:  2005-05-01       Impact factor: 6.860

3.  Metastatic potential correlates with enzymatic degradation of basement membrane collagen.

Authors:  L A Liotta; K Tryggvason; S Garbisa; I Hart; C M Foltz; S Shafie
Journal:  Nature       Date:  1980-03-06       Impact factor: 49.962

4.  Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front.

Authors:  C P Paweletz; L Charboneau; V E Bichsel; N L Simone; T Chen; J W Gillespie; M R Emmert-Buck; M J Roth; E F Petricoin III; L A Liotta
Journal:  Oncogene       Date:  2001-04-12       Impact factor: 9.867

5.  Age-specific incidence rates of in situ breast carcinomas by histologic type, 1980 to 2001.

Authors:  Christopher I Li; Janet R Daling; Kathleen E Malone
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-04       Impact factor: 4.254

6.  Efficient engraftment of human primary breast cancer transplants in nonconditioned NOD/Scid mice.

Authors:  Philipp Beckhove; Florian Schütz; Ingo J Diel; Erich-Franz Solomayer; Gunther Bastert; Joanna Foerster; Markus Feuerer; Lianhua Bai; Hans-Peter Sinn; Viktor Umansky; Volker Schirrmacher
Journal:  Int J Cancer       Date:  2003-07-01       Impact factor: 7.396

Review 7.  Molecular evolution of breast cancer.

Authors:  Peter T Simpson; Jorge S Reis-Filho; Theodora Gale; Sunil R Lakhani
Journal:  J Pathol       Date:  2005-01       Impact factor: 7.996

8.  Large-scale copy number polymorphism in the human genome.

Authors:  Jonathan Sebat; B Lakshmi; Jennifer Troge; Joan Alexander; Janet Young; Pär Lundin; Susanne Månér; Hillary Massa; Megan Walker; Maoyen Chi; Nicholas Navin; Robert Lucito; John Healy; James Hicks; Kenny Ye; Andrew Reiner; T Conrad Gilliam; Barbara Trask; Nick Patterson; Anders Zetterberg; Michael Wigler
Journal:  Science       Date:  2004-07-23       Impact factor: 47.728

9.  Fibroblast hepatocyte growth factor promotes invasion of human mammary ductal carcinoma in situ.

Authors:  Christopher Jedeszko; Bernadette C Victor; Izabela Podgorski; Bonnie F Sloane
Journal:  Cancer Res       Date:  2009-11-17       Impact factor: 12.701

Review 10.  Heterogeneity of duct carcinoma in situ (DCIS): relationship of grade and subtype analysis to local recurrence and risk of invasive transformation.

Authors:  M D Lagios
Journal:  Cancer Lett       Date:  1995-03-23       Impact factor: 8.679

View more
  63 in total

Review 1.  Autophagy in stem and progenitor cells.

Authors:  Carlo Rodolfo; Sabrina Di Bartolomeo; Francesco Cecconi
Journal:  Cell Mol Life Sci       Date:  2015-10-26       Impact factor: 9.261

Review 2.  Reverse phase protein microarrays advance to use in clinical trials.

Authors:  Claudius Mueller; Lance A Liotta; Virginia Espina
Journal:  Mol Oncol       Date:  2010-10-16       Impact factor: 6.603

Review 3.  Autophagy, cancer stem cells and drug resistance.

Authors:  Alexandra G Smith; Kay F Macleod
Journal:  J Pathol       Date:  2019-02-04       Impact factor: 7.996

4.  Non-enzymatic, serum-free tissue culture of pre-invasive breast lesions for spontaneous generation of mammospheres.

Authors:  Virginia Espina; Kirsten H Edmiston; Lance A Liotta
Journal:  J Vis Exp       Date:  2014-11-08       Impact factor: 1.355

Review 5.  Autophagy and cell reprogramming.

Authors:  Shuo Wang; Pengyan Xia; Markus Rehm; Zusen Fan
Journal:  Cell Mol Life Sci       Date:  2015-01-09       Impact factor: 9.261

Review 6.  Functional Role of miRNAs in the Progression of Breast Ductal Carcinoma in Situ.

Authors:  Bethany N Hannafon; Wei-Qun Ding
Journal:  Am J Pathol       Date:  2018-09-29       Impact factor: 4.307

Review 7.  The Role of Autophagy in the Maintenance of Stemness and Differentiation of Mesenchymal Stem Cells.

Authors:  Francesca Vittoria Sbrana; Margherita Cortini; Sofia Avnet; Francesca Perut; Marta Columbaro; Angelo De Milito; Nicola Baldini
Journal:  Stem Cell Rev Rep       Date:  2016-12       Impact factor: 5.739

8.  Differential Expression of Key Signaling Proteins in MCF10 Cell Lines, a Human Breast Cancer Progression Model.

Authors:  Jae Young So; Hong Jin Lee; Pavel Kramata; Audrey Minden; Nanjoo Suh
Journal:  Mol Cell Pharmacol       Date:  2012-01-01

9.  Analysis of the Transcriptome: Regulation of Cancer Stemness in Breast Ductal Carcinoma In Situ by Vitamin D Compounds.

Authors:  Naing Lin Shan; Audrey Minden; Philip Furmanski; Min Ji Bak; Li Cai; Roman Wernyj; Davit Sargsyan; David Cheng; Renyi Wu; Hsiao-Chen D Kuo; Shanyi N Li; Mingzhu Fang; Hubert Maehr; Ah-Ng Kong; Nanjoo Suh
Journal:  Cancer Prev Res (Phila)       Date:  2020-05-28

10.  Characterization of a stem-like subpopulation in basal-like ductal carcinoma in situ (DCIS) lesions.

Authors:  Qinglin Li; Gabriel Eades; Yuan Yao; Yongshu Zhang; Qun Zhou
Journal:  J Biol Chem       Date:  2013-12-02       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.